Advertisement
Screener

PULMATRIX, INC. (PULM) Increase (Decrease) in Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

PULMATRIX, INC. Increase (Decrease) in Accrued Liabilities

PULMATRIX, INC. (PULM) reported Increase (Decrease) in Accrued Liabilities of $103.00 thousand for the 6-month period ending 2026-06-30, per its S-4/A filed 2026-09-17.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-09-17

  • PULMATRIX, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$44.00K.
  • PULMATRIX, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $147.00K, a 16.67% increase year-over-year.
  • PULMATRIX, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$123.00K.
  • PULMATRIX, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $16.00K.
  • PULMATRIX, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$1.08M, a 366.67% decline from fiscal 2022.
  • PULMATRIX, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $405.00K.
  • PULMATRIX, INC. increase (decrease) in accrued liabilities for fiscal 2021 was -$795.00K.
  • PULMATRIX, INC. increase (decrease) in accrued liabilities for fiscal 2020 was -$486.00K, a 154.92% decline from fiscal 2019.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 12 month
2026-06-30-$44.00K
derived: S-4/A 6 month − S-4/A 3 month · filed 2026-09-17
$103.00K
S-4/A · filed 2026-09-17
-$20.00K
derived: sum of 3 quarters · filed 2026-09-17
-$4.00K
derived: sum of 4 quarters · filed 2026-09-17
2026-03-31$147.00K
S-4/A · filed 2026-08-03
$24.00K
derived: sum of 2 quarters · filed 2026-09-17
$40.00K
derived: sum of 3 quarters · filed 2026-09-17
-$42.00K
derived: sum of 4 quarters · filed 2026-09-17
2025-12-31-$123.00K
derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17
-$107.00K
derived: sum of 2 quarters · filed 2026-09-17
-$189.00K
derived: sum of 3 quarters · filed 2026-09-17
-$63.00K
S-4/A · filed 2026-09-17
2025-09-30$16.00K
derived: 10-Q 9 month − S-4/A 6 month · filed 2025-10-16
-$66.00K
derived: sum of 2 quarters · filed 2026-09-17
$60.00K
10-Q · filed 2025-10-16
-$37.00K
derived: sum of 4 quarters · filed 2026-09-17
2025-06-30-$82.00K
derived: S-4/A 6 month − S-4/A 3 month · filed 2026-09-17
$44.00K
S-4/A · filed 2026-09-17
-$53.00K
derived: sum of 3 quarters · filed 2026-09-17
-$1.62M
derived: sum of 4 quarters · filed 2026-09-17
2025-03-31$126.00K
S-4/A · filed 2026-08-03
$29.00K
derived: sum of 2 quarters · filed 2026-09-17
-$1.54M
derived: sum of 3 quarters · filed 2026-09-17
-$1.19M
derived: sum of 4 quarters · filed 2026-09-17
2024-12-31-$97.00K
derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17
-$1.66M
derived: sum of 2 quarters · filed 2026-09-17
-$1.31M
derived: sum of 3 quarters · filed 2026-09-17
-$438.00K
S-4/A · filed 2026-09-17
2024-09-30-$1.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-16
-$1.22M
derived: sum of 2 quarters · filed 2025-10-16
-$341.00K
10-Q · filed 2025-10-16
-$1.65M
derived: sum of 4 quarters · filed 2025-10-16
2024-06-30$350.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$1.23M
10-Q · filed 2025-08-06
-$88.00K
derived: sum of 3 quarters · filed 2025-08-06
$582.00K
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31$875.00K
10-Q · filed 2025-05-15
-$438.00K
derived: sum of 2 quarters · filed 2025-05-15
$232.00K
derived: sum of 3 quarters · filed 2025-05-15
-$229.00K
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21
-$643.00K
derived: sum of 2 quarters · filed 2025-03-21
-$1.10M
derived: sum of 3 quarters · filed 2025-03-21
-$1.08M
10-K · filed 2025-03-21
2023-09-30$670.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$209.00K
derived: sum of 2 quarters · filed 2024-11-08
$233.00K
10-Q · filed 2024-11-08
-$877.00K
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30-$461.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$437.00K
10-Q · filed 2024-08-13
-$1.55M
derived: sum of 3 quarters · filed 2024-08-13
-$409.00K
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$24.00K
10-Q · filed 2024-05-10
-$1.09M
derived: sum of 2 quarters · filed 2024-05-10
$52.00K
derived: sum of 3 quarters · filed 2024-05-10
$595.00K
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31-$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$28.00K
derived: sum of 2 quarters · filed 2024-03-28
$571.00K
derived: sum of 3 quarters · filed 2024-03-28
$405.00K
10-K · filed 2024-03-28
2022-09-30$1.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$1.68M
derived: sum of 2 quarters · filed 2023-11-09
$1.51M
10-Q · filed 2023-11-09
$1.36M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$543.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$377.00K
10-Q · filed 2023-08-10
$225.00K
derived: sum of 3 quarters · filed 2023-08-10
$419.00K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$166.00K
10-Q · filed 2023-05-12
-$318.00K
derived: sum of 2 quarters · filed 2023-05-12
-$124.00K
derived: sum of 3 quarters · filed 2023-05-12
-$801.00K
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31-$152.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$42.00K
derived: sum of 2 quarters · filed 2023-03-30
-$635.00K
derived: sum of 3 quarters · filed 2023-03-30
-$795.00K
10-K · filed 2023-03-30
2021-09-30$194.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$483.00K
derived: sum of 2 quarters · filed 2022-11-10
-$643.00K
10-Q · filed 2022-11-10
-$1.00M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$677.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
-$837.00K
10-Q · filed 2022-08-10
-$1.20M
derived: sum of 3 quarters · filed 2022-08-10
-$2.25M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31-$160.00K
10-Q · filed 2022-05-12
-$521.00K
derived: sum of 2 quarters · filed 2022-05-12
-$1.58M
derived: sum of 3 quarters · filed 2022-05-12
-$1.68M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$361.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
-$1.42M
derived: sum of 2 quarters · filed 2022-03-29
-$1.52M
derived: sum of 3 quarters · filed 2022-03-29
-$486.00K
10-K · filed 2022-03-29
2020-09-30-$1.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
-$1.16M
derived: sum of 2 quarters · filed 2021-11-10
-$125.00K
10-Q · filed 2021-11-10
$1.17M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$103.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
$931.00K
10-Q · filed 2021-08-10
$2.23M
derived: sum of 3 quarters · filed 2021-08-10
$2.27M
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$1.03M
10-Q · filed 2021-05-11
$2.33M
derived: sum of 2 quarters · filed 2021-05-11
$2.37M
derived: sum of 3 quarters · filed 2021-05-11
$1.43M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23
$1.34M
derived: sum of 2 quarters · filed 2021-03-23
$391.00K
derived: sum of 3 quarters · filed 2021-03-23
$885.00K
10-K · filed 2021-03-23
2019-09-30$40.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
-$908.00K
derived: sum of 2 quarters · filed 2020-11-12
-$414.00K
10-Q · filed 2020-11-12
-$982.00K
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$948.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$454.00K
10-Q · filed 2020-08-07
-$1.02M
derived: sum of 3 quarters · filed 2020-08-07
-$1.01M
derived: sum of 4 quarters · filed 2020-08-07
2019-03-31$494.00K
10-Q · filed 2020-05-14
-$74.00K
derived: sum of 2 quarters · filed 2020-05-14
-$61.00K
derived: sum of 3 quarters · filed 2020-05-14
-$33.00K
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$568.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
-$555.00K
derived: sum of 2 quarters · filed 2020-03-26
-$527.00K
derived: sum of 3 quarters · filed 2020-03-26
-$221.00K
10-K · filed 2020-03-26
2018-09-30$13.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01
$41.00K
derived: sum of 2 quarters · filed 2019-11-01
$347.00K
10-Q · filed 2019-11-01
$903.00K
derived: sum of 4 quarters · filed 2019-11-01
2018-06-30$28.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05
$334.00K
10-Q · filed 2019-08-05
$890.00K
derived: sum of 3 quarters · filed 2019-08-05
-$127.00K
derived: sum of 4 quarters · filed 2019-08-05
2018-03-31$306.00K
10-Q · filed 2019-05-15
$862.00K
derived: sum of 2 quarters · filed 2019-05-15
-$155.00K
derived: sum of 3 quarters · filed 2019-05-15
$964.00K
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$556.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19
-$461.00K
derived: sum of 2 quarters · filed 2019-02-19
$658.00K
derived: sum of 3 quarters · filed 2019-02-19
$754.00K
10-K · filed 2019-02-19
2017-09-30-$1.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$102.00K
derived: sum of 2 quarters · filed 2018-11-14
$198.00K
10-Q · filed 2018-11-14
$288.00K
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$1.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
$1.22M
10-Q · filed 2018-08-03
$1.30M
derived: sum of 3 quarters · filed 2018-08-03
$1.25M
derived: sum of 4 quarters · filed 2018-08-03
2017-03-31$96.00K
10-Q · filed 2018-05-11
$186.00K
derived: sum of 2 quarters · filed 2018-05-11
$131.00K
derived: sum of 3 quarters · filed 2018-05-11
$246.00K
derived: sum of 4 quarters · filed 2018-05-11
2016-12-31$90.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
$35.00K
derived: sum of 2 quarters · filed 2018-03-13
$150.00K
derived: sum of 3 quarters · filed 2018-03-13
-$312.00K
10-K · filed 2018-03-13
2016-09-30-$55.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$60.00K
derived: sum of 2 quarters · filed 2017-11-09
-$402.00K
10-Q · filed 2017-11-09
-$38.00K
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$115.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
-$347.00K
10-Q · filed 2017-08-04
$17.00K
derived: sum of 3 quarters · filed 2017-08-04
$111.00K
derived: sum of 4 quarters · filed 2017-08-04
2016-03-31-$462.00K
10-Q · filed 2017-05-05
-$98.00K
derived: sum of 2 quarters · filed 2017-05-05
-$4.00K
derived: sum of 3 quarters · filed 2017-05-05
$334.00K
derived: sum of 4 quarters · filed 2017-05-05
2015-12-31$364.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
$458.00K
derived: sum of 2 quarters · filed 2017-03-10
$796.00K
derived: sum of 3 quarters · filed 2017-03-10
$1.19M
10-K · filed 2017-03-10
2015-09-30$94.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$432.00K
derived: sum of 2 quarters · filed 2016-11-04
$821.00K
10-Q · filed 2016-11-04
$807.00K
derived: sum of 4 quarters · filed 2016-11-04
2015-06-30$338.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$727.00K
10-Q · filed 2016-08-04
$713.00K
derived: sum of 3 quarters · filed 2016-08-04
$389.00K
derived: sum of 4 quarters · filed 2016-08-04
2015-03-31$389.00K
10-Q · filed 2016-05-05
$375.00K
derived: sum of 2 quarters · filed 2016-05-05
$51.00K
derived: sum of 3 quarters · filed 2016-05-05
2014-12-31-$14.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
-$338.00K
derived: sum of 2 quarters · filed 2016-03-10
-$240.00K
10-K · filed 2016-03-10
2014-09-30-$324.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
-$226.00K
10-Q · filed 2015-11-12
2014-06-30$98.00K
10-Q · filed 2015-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26
SYNLOGIC, INC. (SYBX)United States$0.007B
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B